For Patients | FrançaisFr

Pharmacist Survey

All Questions are Mandatory!

  1. 1.
    Prescriptions of Clarus® for women of child-bearing potential should be limited to ___ days of treatment.
  2. 2.
    Continuation of treatment requires a new prescription.
  3. 3.
    Pregnancy testing, issuing a prescription and dispensing of Clarus® should occur on the same day.
  4. 4.
    Dispensing of Clarus® should occur within a maximum of ___ days of the prescription.
  5. 5.
    Have you referred patients to the toll-free number 1- 877-776-7711 or the Clarus® CLEARTM Program Website for more information about birth control or for counselling?
  6. 6.
    How do you access Mylan Pharmaceuticals ULC’s Clinical Education and Awareness Resource (CLEARTM)?
  7. 7.
    The patient must have ___ negative pregnancy tests before starting Clarus® therapy with the first pregnancy test conducted at initial assessment.
  8. 8.
    Pregnancy tests must be repeated at one month after discontinuation of treatment.
  9. 9.
    Clarus® should be stored at controlled room temperature (15°C to 30°C). Store in the original package. Protect from exposure to heat and light. Clarus® does not need to be refrigerated.
  10. 10.
    Patients should take Clarus® with food or just after a meal.
  11. 11.
    Which of the following is an important identified risk of Clarus®?
Submit